1. Home
  2. GAB vs ENOV Comparison

GAB vs ENOV Comparison

Compare GAB & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAB
  • ENOV
  • Stock Information
  • Founded
  • GAB 1986
  • ENOV 1995
  • Country
  • GAB United States
  • ENOV United States
  • Employees
  • GAB N/A
  • ENOV 7367
  • Industry
  • GAB Investment Managers
  • ENOV Fluid Controls
  • Sector
  • GAB Finance
  • ENOV Industrials
  • Exchange
  • GAB Nasdaq
  • ENOV Nasdaq
  • Market Cap
  • GAB 1.9B
  • ENOV 1.8B
  • IPO Year
  • GAB N/A
  • ENOV 2008
  • Fundamental
  • Price
  • GAB $5.98
  • ENOV $27.89
  • Analyst Decision
  • GAB
  • ENOV Strong Buy
  • Analyst Count
  • GAB 0
  • ENOV 6
  • Target Price
  • GAB N/A
  • ENOV $51.00
  • AVG Volume (30 Days)
  • GAB 667.8K
  • ENOV 792.8K
  • Earning Date
  • GAB 01-01-0001
  • ENOV 11-06-2025
  • Dividend Yield
  • GAB 10.91%
  • ENOV N/A
  • EPS Growth
  • GAB N/A
  • ENOV N/A
  • EPS
  • GAB N/A
  • ENOV N/A
  • Revenue
  • GAB N/A
  • ENOV $2,233,266,000.00
  • Revenue This Year
  • GAB N/A
  • ENOV $9.13
  • Revenue Next Year
  • GAB N/A
  • ENOV $6.39
  • P/E Ratio
  • GAB N/A
  • ENOV N/A
  • Revenue Growth
  • GAB N/A
  • ENOV 11.57
  • 52 Week Low
  • GAB $4.56
  • ENOV $25.47
  • 52 Week High
  • GAB $5.88
  • ENOV $49.83
  • Technical
  • Relative Strength Index (RSI)
  • GAB 46.88
  • ENOV 31.74
  • Support Level
  • GAB $5.97
  • ENOV $29.76
  • Resistance Level
  • GAB $6.12
  • ENOV $32.13
  • Average True Range (ATR)
  • GAB 0.06
  • ENOV 1.22
  • MACD
  • GAB -0.00
  • ENOV -0.43
  • Stochastic Oscillator
  • GAB 26.87
  • ENOV 2.19

About GAB Gabelli Equity Trust Inc. (The)

Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

Share on Social Networks: